A team of researchers inside Pfizer made a startling find in 2015: The company’s blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimer’s disease by 64 percent.
Democracy Dies in Darkness
Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world?
June 4, 2019 at 7:05 p.m. EDT